Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Sjogren’s syndrome
•
Neurology
•
Neuro-immunology
What is your initial treatment paradigm for someone with both CNS and peripheral neurologic Sjogren’s?
Related Questions
How would you treat chorea in a patient with Sjögren’s syndrome and positive beta 2 glycoprotein I antibodies?
What is your treatment approach to neuropsychiatric symptoms secondary to lupus?
What is your workup and treatment approach for cranial neuropathies in patients with lupus?
Should IVIG dosing in patients with autoimmune disease (i.e., dermatomyositis) who become pregnant continue to be based on actual weight at the time of each infusion, or should it be limited to pre-pregnancy weight?
Do you consider immunosuppression in patients with a history of Sjogren's disease and clinical features of inclusion body myositis?
For patients on anti-CD20 therapy for MS without frequent/opportunistic infections, are there serum IgG levels or ALC levels in which you pause or change therapy due to low levels?
When do you start cyclophosphamide for the treatment of anti-NMDA receptor encephalitis?
Is it necessary to prescribe a steroid taper after two weeks of high-dose prednisone (60 mg daily)?
How do you decide on initial and sequential anti-CD20 therapy for patients with multiple sclerosis given the availability of rituximab, ocrelizumab, ublituximab, and ofatumumab?
In a patient with sicca symptoms and SS-B antibodies only, can a minor salivary gland lip biopsy with lymphoid aggregates, but also scattered areas of acute neutrophilic inflammation be consistent with Sjogren's Disease?
